Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.32
-0.35 (-3.57%)
Feb 21, 2025, 4:00 PM EST - Market closed
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $458.06 million as of February 21, 2025. Its market cap has increased by 4.29% in one year.
Market Cap
458.06M
Enterprise Value
411.68M
1-Year Change
4.29%
Ranking
Category
Stock Price
$9.32
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $458.06M, a decrease of -38.16%. That is a compound annual growth rate of -4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 458.10M | -0.99% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |